Enovis CORP cotiza a 18.99 USD y tiene una capitalización bursátil de $1.1B. En los últimos 12 meses ha facturado $2.3B con un margen de flujo de caja libre del 0.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.90 | $0.89 | $0.95 |
| Estimado | $0.77 | $0.85 | $0.81 | $0.84 |
| Sorpresa | — | +5.9% | +9.9% | +13.1% |
| Métrica | ENOV | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 59.8% | 57.0% | +2.8% |
| Operating Margin | -50.0% | -38.6% | -11.4% |
| Net Margin | -52.7% | -33.6% | -19.1% |
| FCF Margin | 0.9% | -13.9% | +14.8% |
| ROE | -79.5% | -40.4% | -39.1% |
| ROA | -30.9% | -32.0% | +1.1% |
| Current Ratio | 2.02 | 2.84 | -0.82 |
| Debt / Equity | 0.87 | 0.28 | +0.59 |